The purpose of the development and commercialization of porcine parvovirus inactivated vaccine is to control the sow abortion and newborn-piglet death occurred in Taiwan. This year, an efford will make to complete the seed virus multiplication, best adjuvant selection and laboratory trial of the test vaccine. The anticipated successful delvelopment of this vaccine will reduce the financial losses of the pig farmers.